Hudson Canyon Capital Management Eli Lilly & CO Transaction History

Hudson Canyon Capital Management

$155 Billion
Q3 2024

A detailed history of Hudson Canyon Capital Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Hudson Canyon Capital Management holds 4,683 shares of LLY stock, worth $3.51 Million. This represents 2.68% of its overall portfolio holdings.

Number of Shares

4,683

Previous 4,683 -0.0%

Holding current value

$3.51 Million

Previous $4.24 Billion 2.15%

% of portfolio

2.68%

Previous 2.87%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$724.87 - $909.04 $486,387 - $609,965	-671 Reduced 12.53%	4,683 $4.24 Billion
Q4 2023 Jan 26, 2024	SELL	$525.19 - $619.13 $63,547 - $74,914	-121 Reduced 2.21%	5,354 $3.12 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $224,739 - $309,838	-517 Reduced 8.63%	5,475 $2.94 Billion
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $66,640 - $89,106	-190 Reduced 3.07%	5,992 $2.81 Billion
Q1 2023 Aug 02, 2023	SELL	$310.63 - $364.82 $10,250 - $12,039	-33 Reduced 0.53%	6,182 $2.12 Billion
Q4 2022 Aug 02, 2023	SELL	$321.55 - $374.67 $252,416 - $294,115	-785 Reduced 11.21%	6,215 $2.27 Billion
Q3 2022 Aug 02, 2023	SELL	$296.48 - $337.87 $118,592 - $135,148	-400 Reduced 5.41%	7,000 $2.26 Billion
Q2 2022 Aug 02, 2023	SELL	$278.73 - $327.27 $420,046 - $493,195	-1,507 Reduced 16.92%	7,400 $2.4 Billion
Q4 2021 Aug 02, 2023	SELL	$224.85 - $279.04 $99,383 - $123,335	-442 Reduced 4.73%	8,907 $2.46 Billion
Q3 2021 Aug 02, 2023	SELL	$221.6 - $272.71 $77,781 - $95,721	-351 Reduced 3.62%	9,349 $2.16 Billion
Q2 2021 Aug 02, 2023	SELL	$180.55 - $233.54 $134,148 - $173,520	-743 Reduced 7.11%	9,700 $2.23 Billion
Q1 2021 Aug 02, 2023	SELL	$164.32 - $212.72 $160,047 - $207,189	-974 Reduced 8.53%	10,443 $1.95 Billion
Q4 2020 Aug 02, 2023	BUY	$130.46 - $172.63 $1.49 Million - $1.97 Million	11,417 New	11,417 $1.93 Billion

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Canyon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Canyon Capital Management with notifications on news.

Account

Hudson Canyon Capital Management Eli Lilly & CO Transaction History